James Schaub - 18 May 2023 Form 4 Insider Report for RVL Pharmaceuticals plc

Signature
/s/ Christopher Klein, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
18 May 2023
Net transactions value
-$4,852
Form type
4
Filing time
22 May 2023, 21:21:22 UTC
Previous filing
26 Jan 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVLP Ordinary Shares Tax liability $4,852 -5,577 -1.1% $0.8700 524,835 18 May 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.